Use of drugs with potential cardiac effect in the setting of SARS-CoV-2 infection.

Use of drugs with potential cardiac effect in the setting of SARS-CoV-2 infection.
Arch Cardiovasc Dis. 2020 Apr 24;:
Authors: Sacher F, Fauchier L, Boveda S, de Chillou C, Defaye P, Deharo JC, Gandjbakhch E, Probst V, Cohen A, Leclercq C, Working Group of Pacing, Electrophysiology of the French Society of Cardiology, the Board of the French Society of Cardiology
PMID: 32354666 [PubMed - as supplied by publisher]

Source: Archives of Cardiovascular Diseases - April 23, 2020 Category: Cardiology Authors: Sacher F, Fauchier L, Boveda S, de Chillou C, Defaye P, Deharo JC, Gandjbakhch E, Probst V, Cohen A, Leclercq C, Working Group of Pacing, Electrophysiology of the French Society of Cardiology, the Board of the French Society of Cardiology Tags: Arch Cardiovasc Dis Source Type: research